|
Dr. Nisbet is one of the best credentialed and most respected biotechnology executives in Australia, with a significant track record of achievement both in Australia and the United States. In the U.S., Dr. Nisbet worked at Millennium Pharmaceuticals, Inc., Cambridge, MA for almost seven years in a variety of senior positions, mostly related to product in-licensing and mergers and acquisitions. He was Product Leader for VELCADE®, leading the team that was responsible for obtaining FDA approval and launching this novel oncology drug in May 2003. Before joining Millennium, Dr. Nisbet worked for CSL Limited for more than 17 years, where he held a number of scientific and management positions, the last being Director, Planning and Coordination. | 